{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:13:22Z","timestamp":1791263602282,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1323,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.semcancer.2009.07.007","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T09:30:12Z","timestamp":1248600612000},"page":"366-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["How does Epstein\u2013Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?"],"prefix":"10.1016","volume":"19","author":[{"given":"Martin J.","family":"Allday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2009.07.007_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt's lymphoma","volume":"55","author":"Magrath","year":"1990","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.semcancer.2009.07.007_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrmicro1089","article-title":"Endemic Burkitt's lymphoma: a polymicrobial disease?","volume":"3","author":"Rochford","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumour virus: 50 years of Burkitt's lymphoma","volume":"6","author":"Thorley-Lawson","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","article-title":"Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype","volume":"139","author":"Gregory","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib5","first-page":"2511","article-title":"Epstein\u2013Barr virus","volume":"vol. 2","author":"Rickinson","year":"2001"},{"key":"10.1016\/j.semcancer.2009.07.007_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt's lymphoma Epstein\u2013Barr virus phenotype in dividing latently infected memory cells in vivo","volume":"101","author":"Hochberg","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein\u2013Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02609-08","article-title":"The intersection of Epstein\u2013Barr virus with the germinal center","author":"Roughan","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1098\/rstb.2000.0783","article-title":"Biology and disease associations of Epstein\u2013Barr virus","volume":"356","author":"Crawford","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.semcancer.2009.07.007_bib10","first-page":"341","article-title":"Translocations among antibody genes in human cancer","author":"Leder","year":"1985","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.semcancer.2009.07.007_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/(SICI)1521-1878(200005)22:5<414::AID-BIES3>3.0.CO;2-5","article-title":"Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes","volume":"22","author":"Klein","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.semcancer.2009.07.007_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-2776(06)94008-5","article-title":"Role of AID in tumorigenesis","volume":"94","author":"Okazaki","year":"2007","journal-title":"Adv Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib13","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1073\/pnas.95.5.2463","article-title":"Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease","volume":"95","author":"Goossens","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng.2007.35","article-title":"AID is required for germinal center-derived lymphomagenesis","volume":"40","author":"Pasqualucci","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2009.07.007_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0065-2776(06)94003-6","article-title":"The role of activation-induced deaminase in antibody diversification and chromosome translocations","volume":"94","author":"Ramiro","year":"2007","journal-title":"Adv Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib17","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0993-56","article-title":"Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas","volume":"5","author":"Bhatia","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2009.07.007_bib19","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/MCB.20.12.4309-4319.2000","article-title":"The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals","volume":"20","author":"Chang","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib20","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/MCB.20.7.2423-2435.2000","article-title":"c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells","volume":"20","author":"Gregory","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1532","article-title":"Reverse engineering of regulatory networks in human B cells","volume":"37","author":"Basso","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2009.07.007_bib23","doi-asserted-by":"crossref","first-page":"17834","DOI":"10.1073\/pnas.0604129103","article-title":"Global mapping of c-Myc binding sites and target gene networks in human B cells","volume":"103","author":"Zeller","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib24","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1038\/sj.onc.1207261","article-title":"Myc pathways provoking cell suicide and cancer","volume":"22","author":"Nilsson","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrm1987","article-title":"Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all","volume":"7","author":"Gil","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib26","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Hoffman","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0960-9822(99)80507-7","article-title":"Control of cell growth by c-Myc in the absence of cell division","volume":"9","author":"Schuhmacher","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07449","article-title":"Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency","volume":"456","author":"Barna","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.07.007_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O\u2019Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.07.007_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2009.07.007_bib31","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","article-title":"MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells","volume":"67","author":"Sampson","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2009.07.007_bib32","first-page":"8","article-title":"Repressing the repressor: a new mode of MYC action in lymphomagenesis","author":"Sander","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2009.07.007_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.07.007_bib34","first-page":"1915","article-title":"Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis","volume":"6","author":"Askew","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","article-title":"Induction of apoptosis in fibroblasts by c-myc protein","volume":"69","author":"Evan","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib36","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1101\/gad.12.19.2984","article-title":"Tumor surveillance via the ARF-p53 pathway","volume":"12","author":"Sherr","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcancer.2009.07.007_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature03098","article-title":"Intrinsic tumour suppression","volume":"432","author":"Lowe","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.07.007_bib38","first-page":"2508","article-title":"Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells","volume":"57","author":"Cherney","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2009.07.007_bib39","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1101\/gad.12.15.2424","article-title":"Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization","volume":"12","author":"Zindy","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcancer.2009.07.007_bib40","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcancer.2009.07.007_bib41","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2005.03.183","article-title":"Death squads enlisted by the tumour suppressor p53","volume":"331","author":"Michalak","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semcancer.2009.07.007_bib42","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: the cell's response to p53","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2009.07.007_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","article-title":"p53 has a direct apoptogenic role at the mitochondria","volume":"11","author":"Mihara","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","article-title":"Role of genetic and epigenetic changes in Burkitt lymphoma","volume":"12","author":"Lindstrom","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1568","article-title":"The role of BH3-only proteins in the immune system","volume":"5","author":"Strasser","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib46","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature07396","article-title":"BAX activation is initiated at a novel interaction site","volume":"455","author":"Gavathiotis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.07.007_bib47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1084\/jem.20030411","article-title":"Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells","volume":"198","author":"Enders","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib48","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/blood-2007-05-091306","article-title":"Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells","volume":"110","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib49","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukaemia","volume":"101","author":"Egle","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","article-title":"Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas","volume":"109","author":"Mestre-Escorihuela","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib51","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib52","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.07.007_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccr.2005.08.005","article-title":"The great MYC escape in tumorigenesis","volume":"8","author":"Dang","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0092-8674(00)00046-5","article-title":"Cellular senescence: mitotic clock or culture shock?","volume":"102","author":"Sherr","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib56","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V91.5.1680","article-title":"p16\/INK4a and p15\/INK4b gene methylation and absence of p16\/INK4a mRNA and protein expression in Burkitt's lymphoma","volume":"91","author":"Klangby","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1098\/rstb.2000.0781","article-title":"Molecular virology of Epstein\u2013Barr virus","volume":"356","author":"Bornkamm","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.semcancer.2009.07.007_bib58","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib59","first-page":"99","article-title":"Epstein\u2013Barr virus and lymphomas","volume":"33","author":"Brooks","year":"1999","journal-title":"Cancer Surveys"},{"key":"10.1016\/j.semcancer.2009.07.007_bib60","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1002-1086","article-title":"EBV framed in Burkitt lymphoma","volume":"8","author":"Speck","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib61","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein\u2013Barr virus provides a survival factor to Burkitt's lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2005.02.029","article-title":"Structure of the p53 binding domain of HAUSP\/USP7 bound to Epstein\u2013Barr nuclear antigen 1 implications for EBV-mediated immortalization","volume":"18","author":"Saridakis","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib63","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/j.1460-2075.1995.tb07124.x","article-title":"Epstein\u2013Barr virus efficiently immortalizes human B cells without neutralizing the function of p53","volume":"14","author":"Allday","year":"1995","journal-title":"Embo J"},{"key":"10.1016\/j.semcancer.2009.07.007_bib64","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1128\/JVI.01363-06","article-title":"Epstein\u2013Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53","volume":"80","author":"O\u2019Nions","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib65","doi-asserted-by":"crossref","first-page":"12694","DOI":"10.1128\/JVI.78.22.12694-12697.2004","article-title":"EBNA2 is required for protection of latently Epstein\u2013Barr virus-infected B cells against specific apoptotic stimuli","volume":"78","author":"Lee","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib66","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1073\/pnas.182552499","article-title":"Epstein\u2013Barr virus EBNA2 blocks Nur77-mediated apoptosis","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib67","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20080101","article-title":"During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain","volume":"205","author":"Thompson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.icb.7100141","article-title":"What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain","volume":"86","author":"Strasser","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib69","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1128\/JVI.00278-06","article-title":"Epstein\u2013Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1\/RBPJ kappa-dependent pathway","volume":"80","author":"Pegman","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib70","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1038\/sj.onc.1210363","article-title":"Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis","volume":"26","author":"Brien","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib71","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/j.febslet.2008.09.028","article-title":"Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim","volume":"582","author":"Herman","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.semcancer.2009.07.007_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0065-230X(04)92006-4","article-title":"Deregulation of the cell cycle by the Epstein\u2013Barr virus","volume":"92","author":"O\u2019Nions","year":"2004","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.semcancer.2009.07.007_bib73","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.4049\/jimmunol.175.5.2968","article-title":"EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis","volume":"175","author":"Clybouw","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib74","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/JVI.01096-06","article-title":"Epstein\u2013Barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells","volume":"81","author":"Leao","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib75","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1099\/vir.0.2008\/001461-0","article-title":"EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK\/MAPK pathway","volume":"89","author":"Anderson","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.onc.1210668","article-title":"Two Epstein\u2013Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma","volume":"27","author":"Anderton","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib77","doi-asserted-by":"crossref","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","article-title":"Epstein\u2013Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim","volume":"5","author":"Paschos","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2009.07.007_bib78","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","article-title":"The proto-oncogene c-myc is a direct target gene of Epstein\u2013Barr virus nuclear antigen 2","volume":"73","author":"Kaiser","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib79","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","article-title":"Induction of bcl-2 expression by Epstein\u2013Barr virus latent membrane protein 1 protects infected B cells from programmed cell death","volume":"65","author":"Henderson","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib80","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","article-title":"The Epstein\u2013Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B","volume":"267","author":"Laherty","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2009.07.007_bib81","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JVI.78.4.1800-1816.2004","article-title":"Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein\u2013Barr virus latent membrane protein 1 and activated CD40 receptor","volume":"78","author":"D'Souza","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib82","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.onc.1208367","article-title":"Latent membrane protein 1 of Epstein\u2013Barr virus coordinately regulates proliferation with control of apoptosis","volume":"24","author":"Dirmeier","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib83","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1038\/sj.onc.1207905","article-title":"Epstein\u2013Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras\/PI3K\/Akt pathway","volume":"23","author":"Portis","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib84","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein\u2013Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2008.492","article-title":"Epstein\u2013Barr virus LMP2A accelerates MYC-induced lymphomagenesis","author":"Bultema","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib86","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"Kovalchuk","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib87","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/j.1460-2075.1989.tb08404.x","article-title":"EBV gene expression in an NPC-related tumour","volume":"8","author":"Hitt","year":"1989","journal-title":"Embo J"},{"key":"10.1016\/j.semcancer.2009.07.007_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jcp.21480","article-title":"Noncoding RNAs produced by oncogenic human herpesviruses","volume":"216","author":"Swaminathan","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib89","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","article-title":"Epstein\u2013Barr virus microRNAs are evolutionarily conserved and differentially expressed","volume":"2","author":"Cai","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2009.07.007_bib90","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","article-title":"An Epstein\u2013Barr virus-encoded microRNA targets PUMA to promote host cell survival","volume":"205","author":"Choy","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib91","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cdd.2008.14","article-title":"Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur","volume":"15","author":"Cross","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.semcancer.2009.07.007_bib92","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","article-title":"Epstein\u2013Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death","volume":"90","author":"Henderson","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib93","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1128\/JVI.72.10.8392-8395.1998","article-title":"Suppression of c-Myc-induced apoptosis by the Epstein\u2013Barr virus gene product BHRF1","volume":"72","author":"Fanidi","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib94","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/jvi.76.5.2469-2479.2002","article-title":"Epstein\u2013Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins","volume":"76","author":"Bellows","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib95","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1371\/journal.pbio.0030404","article-title":"Epstein\u2013Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis","volume":"3","author":"Altmann","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib96","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1099\/vir.0.19704-0","article-title":"Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein\u2013Barr virus or T cell-derived mitogens","volume":"85","author":"O\u2019Nions","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib97","first-page":"2541","article-title":"Epstein\u2013Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7","volume":"13","author":"Parker","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib98","doi-asserted-by":"crossref","first-page":"19500","DOI":"10.1073\/pnas.0604919104","article-title":"Epstein\u2013Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells","volume":"103","author":"Maruo","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib99","doi-asserted-by":"crossref","first-page":"47197","DOI":"10.1074\/jbc.M208116200","article-title":"Two nonconsensus sites in the Epstein\u2013Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP)","volume":"277","author":"Hickabottom","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2009.07.007_bib100","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1128\/JVI.77.19.10437-10447.2003","article-title":"Epstein\u2013Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth","volume":"77","author":"Maruo","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib101","doi-asserted-by":"crossref","first-page":"e1000506","DOI":"10.1371\/journal.ppat.1000506","article-title":"Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes","volume":"5","author":"Hertle","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2009.07.007_bib102","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.onc.1203515","article-title":"LMP1 of Epstein\u2013Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression","volume":"19","author":"Yang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1083\/jcb.200302085","article-title":"Epstein\u2013Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4\/5","volume":"162","author":"Ohtani","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib104","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","article-title":"EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching","volume":"171","author":"He","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib105","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.73.4.3154-3161.1999","article-title":"Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein\u2013Barr virus type I latency","volume":"73","author":"Davenport","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib106","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1128\/JVI.73.10.7943-7951.1999","article-title":"Repression of Epstein\u2013Barr virus EBNA-1 gene transcription by pRb during restricted latency","volume":"73","author":"Ruf","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib107","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein\u2013Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib108","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.molimm.2008.03.002","article-title":"EBV transformation overrides gene expression patterns of B cell differentiation stages","volume":"45","author":"Siemer","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib109","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2567.2003.01601.x","article-title":"B-lymphocyte subpopulations are equally susceptible to Epstein\u2013Barr virus infection, irrespective of immunoglobulin isotype expression","volume":"108","author":"Ehlin-Henriksson","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.semcancer.2009.07.007_bib110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein\u2013Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2009.07.007_bib111","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1097-2765(02)00520-8","article-title":"c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability","volume":"9","author":"Vafa","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2009.07.007_bib112","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4161\/cc.6.9.4161","article-title":"The ever expanding role for c-Myc in promoting genomic instability","volume":"6","author":"Prochownik","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2009.07.007_bib113","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2007-02-075614","article-title":"The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo","volume":"110","author":"Reimann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.07.007_bib114","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/sj.onc.1207572","article-title":"Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy","volume":"23","author":"Castedo","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/mutage\/16.3.203","article-title":"Enhancement of genetic instability in human B cells by Epstein\u2013Barr virus latent infection","volume":"16","author":"Gualandi","year":"2001","journal-title":"Mutagenesis"},{"key":"10.1016\/j.semcancer.2009.07.007_bib116","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1038\/sj.onc.1210324","article-title":"Epstein\u2013Barr virus promotes genomic instability in Burkitt's lymphoma","volume":"26","author":"Kamranvar","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib117","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1073\/pnas.0810619106","article-title":"From the cover: the Epstein\u2013Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species","volume":"106","author":"Gruhne","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.07.007_bib118","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/MCB.20.4.1344-1360.2000","article-title":"Epstein\u2013Barr virus suppresses a G(2)\/M checkpoint activated by genotoxins","volume":"20","author":"Wade","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib119","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.onc.1203327","article-title":"Epstein\u2013Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis","volume":"19","author":"Parker","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib120","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/sj.onc.1207253","article-title":"The EBNA-3 gene family proteins disrupt the G2\/M checkpoint","volume":"23","author":"Krauer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.07.007_bib121","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/JVI.00053-07","article-title":"The ATM\/ATR signaling effector Chk2 is targeted by Epstein\u2013Barr virus nuclear antigen 3C to release the G2\/M cell cycle block","volume":"81","author":"Choudhuri","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib122","first-page":"605","volume":"28","author":"Karpova","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.semcancer.2009.07.007_bib123","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/nm758","article-title":"Epstein\u2013Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2","volume":"8","author":"Kelly","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2009.07.007_bib124","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","article-title":"Epstein\u2013Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis","volume":"79","author":"Kelly","year":"2005","journal-title":"J Virol"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X09000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X09000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:27:45Z","timestamp":1760916465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X09000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1044579X09000704"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2009.07.007","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How does Epstein\u2013Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2009.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}